Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4+ regulatory T cells to impair CD8+ T‐cell immunity against hepatitis B virus infection

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2567|144|3|506-517

ISSN: 0019-2805

Source: IMMUNOLOGY, Vol.144, Iss.3, 2015-03, pp. : 506-517

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract